Mesoporous Silica Nanoparticles for Targeted Aβ42 Imaging and Therapy in Traumatic Brain Injury: Enhanced Blood–Brain Barrier Penetration and Sustained Drug Delivery
Authors:
- 22 May 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 8 (22) , 11322-11337
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Pre-clinical evaluation of 99mTc-labeled chalcone derivative for amyloid-β imaging post-head traumaJBIC Journal of Biological Inorganic Chemistry, 2024
- Potential applications of mesoporous silica nanoparticles for the treatment of neurological disordersJournal of Drug Delivery Science and Technology, 2023
- The roles of gold nanoparticles in the detection of amyloid-β peptide for Alzheimer's diseaseColloid and Interface Science Communications, 2022
- Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer’s diseaseBioorganic Chemistry, 2021
- Synthesis and characterization of a novel organosilane-functionalized chitosan nanocarrier as an efficient gene delivery system: Expression of green fluorescent proteinInternational Journal of Biological Macromolecules, 2019
- Transferrin‐conjugated magnetic dextran‐spermine nanoparticles for targeted drug transport across blood‐brain barrierJournal of Biomedical Materials Research Part A, 2017
- Fluorescent 2-styrylpyridazin-3(2H)-one derivatives as probes targeting amyloid-beta plaques in Alzheimer’s diseaseBioorganic & Medicinal Chemistry Letters, 2012
- A mouse model of human repetitive mild traumatic brain injuryJournal of Neuroscience Methods, 2012
- Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse modelHippocampus, 2009
- The analysis of ancient glasses part I: Materials, properties, and early European glassJOM, 1995